The Industrial Phase-Transfer Catalysis Experts

PTC Tip of the Month E-Newsletter

PTC Catalyst of the Month - September 2025

Role of TEBA Cl in an Esterification with Glycidyl Methacrylate

By Marc Halpern, the leading expert in industrial phase-transfer catalysis.

The use of triethyl benzyl ammonium (TEBA) chloride was reported for the reaction shown in the diagram.

The reaction was between methacrylic acid and glycidyl methacrylate that ring-opened the epoxide followed by esterification to produce glycerol dimethacrylate that contains very low levels of residual glycidyl methacrylate that is toxic.

Historically, it is known that the halide of a quat halide can initiate the ring opening of an epoxide to form a halohydrin intermediate, then the halide can serve as a leaving group when a nucleophile is present. The use of quat chloride to ring-open an epoxide is known for etherification with alcohols.

In the reaction between methacrylic acid and glycidyl methacrylate (GMA), the methacrylic acid is a very weak nucleophile unless a base is present to neutralize the carboxylic acid. In this case, it is desired to avoid the presence of base due to a variety of potential side reactions.

Accordingly, one may speculate that the quat chloride reacts with GMA forms the chlorohydrin and then the hydroxyl of the neutral carboxylic acid attacks the chlorohydrin to perform the esterification to produce glycerol dimethacrylate. Perhaps the weak nucleophilicity of the neutral methacrylic acid is strong enough to perform this attack at the elevated temperature of 97-100 deg C for 10 hours.

The choice of TEBA as the quat is questionable since this quat is not very stable at 100 deg C for many hours in the presence of nucleophiles. The same temperature that is apparently required to activate the nucleophilicity of the neutral carboxylic acid, may undesirably cause the attack of the methacrylic acid on the benzyl group of benzyl triethylammonium chloride that would produce benzyl methacrylate and triethyl amine as the leaving group.

This is one reason that at PTC Organics we avoid the use of benzylated quats in industrial commercial PTC applications, especially TEBA since benzylation of the nucleophile is often observed and constitutes an undesired impurity. We would choose more stable quat chloride that do not contain a benzyl group (or an allyl group) since they are labile, especially at higher temperatures such as 100 deg C over many hours.

In my early days using PTC in the 1970’s, I learned the hard way that TEBA chloride causes benzylated impurities even though this phase-transfer catalyst with a q-value of about 1.6 is excellent to promote the reactivity of PTC T-Reactions.

If your company is using benzylated quats, especially TEBA, in commercial processes, you should actively look for benzylated byproducts. If you find them, now contact Marc Halpern of PTC Organics for consulting on the best alternatives for TEBA for your specific application.


About Marc Halpern

Marc Halpern

Dr. Halpern is founder and president of PTC Organics, Inc., the only company dedicated exclusively to developing low-cost high-performance green chemistry processes for the manufacture of organic chemicals using Phase Transfer Catalysis. Dr. Halpern has innovated PTC breakthroughs for pharmaceuticals, agrochemicals, petrochemicals, monomers, polymers, flavors & fragrances, dyes & pigments and solvents. Dr. Halpern has provided PTC services on-site at more than 260 industrial process R&D departments in 37 countries and has helped chemical companies save > $200 million. Dr. Halpern co-authored five books including the best-selling “Phase-Transfer Catalysis: Fundamentals, Applications and Industrial Perspectives” and has presented the 2-day course “Practical Phase-Transfer Catalysis” at 50 locations in the US, Europe and Asia.

Dr. Halpern founded the journal “Industrial Phase-Transfer Catalysis” and “The PTC Tip of the Month” enjoyed by 2,100 qualified subscribers, now beyond 130 issues. In 2014, Dr. Halpern is celebrating his 30th year in the chemical industry, including serving as a process chemist at Dow Chemical, a supervisor of process chemistry at ICI, Director of R&D at Sybron Chemicals and founder and president of PTC Organics Inc. (15 years) and PTC Communications Inc. (20 years). Dr. Halpern also co-founded PTC Interface Inc. in 1989 and PTC Value Recovery Inc. in 1999. His academic breakthroughs include the PTC pKa Guidelines, the q-value for quat accessibility and he has achieved industrial PTC breakthroughs for a dozen strong base reactions as well as esterifications, transesterifications, epoxidations and chloromethylations plus contributed to more than 100 other industrial PTC process development projects.

Dr. Halpern has dedicated his adult life to his family and to phase-transfer catalysis (in that order!).

Leave a Reply

Your email address will not be published. Required fields are marked *